Veracyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia.

CEO

Marc A. Stapley

CEOMarc A. Stapley

Employees

824

Employees824

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2006

Founded2006

Employees

824

Employees824

VCYT Key Statistics

Market cap

2.89B

Market cap2.89B

Price-Earnings ratio

107.69

Price-Earnings ratio107.69

Dividend yield

—

Dividend yield—

Average volume

797.55K

Average volume797.55K

High today

$37.07

High today$37.07

Low today

$36.15

Low today$36.15

Open price

$36.40

Open price$36.40

Volume

861.65K

Volume861.65K

52 Week high

$47.32

52 Week high$47.32

52 Week low

$22.61

52 Week low$22.61

VCYT News

TipRanks 17h

Veracyte initiated with a Hold at Canaccord

Canaccord analyst Kyle Mikson initiated coverage of Veracyte (VCYT) with a Hold rating and $40 price target The company’s Afirma tests for thyroid nodule classi...

Analyst ratings

83%

of 12 ratings

Buy

83.3%

Hold

8.3%

Sell

8.3%

People also own

Based on the portfolios of people who own VCYT. This list is generated using Robinhood data, and it’s not a recommendation.